OBJECTIVE: Knowledge of referral patterns for specialty cancer care is sparse. Information on both the need and reasons for referral of high-risk, well-differentiated thyroid cancer patients should provide a foundation for eliminating obstacles to appropriate patient referrals and improving patient care. METHODS: We surveyed 370 endocrinologists involved in thyroid cancer management. From information in a clinical vignette, respondents were asked to identify the reasons they would need to refer a high-risk patient to a more specialized facility for care. We performed multivariable analysis controlling for hospital and physician characteristics. RESULTS: Thirty-two percent of respondents reported never referring thyroid cancer patients to another facility. Of those that would refer a high-risk patient to another facility, the opportunity for a patient to enter a clinical trial was the most common reason reported (44%), followed by high-dose radioactive iodine (RAI) with or without dosimetry (33%), lateral neck dissection (24%), and external beam radiation (15%). In multivariable analysis, endocrinologists with a higher percentage of their practice devoted to thyroid cancer care were significantly less likely to refer patients to another facility (P = .003). CONCLUSION: The majority of endocrinologists treating thyroid cancer patients report referring a high-risk patient to another facility for some or all of their care. Knowledge of the patterns of physician referrals and the likelihood of need for referral are key to understanding discrepancies in referral rates and obstacles in the referral process.
OBJECTIVE: Knowledge of referral patterns for specialty cancer care is sparse. Information on both the need and reasons for referral of high-risk, well-differentiated thyroid cancerpatients should provide a foundation for eliminating obstacles to appropriate patient referrals and improving patient care. METHODS: We surveyed 370 endocrinologists involved in thyroid cancer management. From information in a clinical vignette, respondents were asked to identify the reasons they would need to refer a high-risk patient to a more specialized facility for care. We performed multivariable analysis controlling for hospital and physician characteristics. RESULTS: Thirty-two percent of respondents reported never referring thyroid cancerpatients to another facility. Of those that would refer a high-risk patient to another facility, the opportunity for a patient to enter a clinical trial was the most common reason reported (44%), followed by high-dose radioactive iodine (RAI) with or without dosimetry (33%), lateral neck dissection (24%), and external beam radiation (15%). In multivariable analysis, endocrinologists with a higher percentage of their practice devoted to thyroid cancer care were significantly less likely to refer patients to another facility (P = .003). CONCLUSION: The majority of endocrinologists treating thyroid cancerpatients report referring a high-risk patient to another facility for some or all of their care. Knowledge of the patterns of physician referrals and the likelihood of need for referral are key to understanding discrepancies in referral rates and obstacles in the referral process.
Authors: R Michael Tuttle; Rebecca Leboeuf; Richard J Robbins; Rebecca Qualey; Keith Pentlow; Steven M Larson; Chee Y Chan Journal: J Nucl Med Date: 2006-10 Impact factor: 10.057
Authors: Robert Dorn; Juergen Kopp; Harry Vogt; Peter Heidenreich; Robert G Carroll; Seza A Gulec Journal: J Nucl Med Date: 2003-03 Impact factor: 10.057
Authors: Sin-Ming Chow; Stephen Yau; Chung-Kong Kwan; Patricia C M Poon; Stephen C K Law Journal: Endocr Relat Cancer Date: 2006-12 Impact factor: 5.678
Authors: Karl Y Bilimoria; David J Bentrem; John G Linn; Andrew Freel; Jen Jen Yeh; Andrew K Stewart; David P Winchester; Clifford Y Ko; Mark S Talamonti; Cord Sturgeon Journal: Surgery Date: 2007-11-05 Impact factor: 3.982
Authors: Megan R Haymart; Mousumi Banerjee; Di Yang; Andrew K Stewart; Gerard M Doherty; Ronald J Koenig; Jennifer J Griggs Journal: Ann Surg Date: 2013-08 Impact factor: 12.969
Authors: John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas Journal: N Engl J Med Date: 2003-11-27 Impact factor: 91.245
Authors: Maria Papaleontiou; David T Hughes; Cui Guo; Mousumi Banerjee; Megan R Haymart Journal: J Clin Endocrinol Metab Date: 2017-07-01 Impact factor: 5.958
Authors: Archana Radhakrishnan; David Reyes-Gastelum; Paul Abrahamse; Brittany Gay; Sarah T Hawley; Lauren P Wallner; Debbie W Chen; Ann S Hamilton; Kevin C Ward; Megan R Haymart Journal: J Clin Endocrinol Metab Date: 2022-02-17 Impact factor: 6.134
Authors: Sylvie Stacy; Omar Hyder; David Cosgrove; Joseph M Herman; Ihab Kamel; Jean-Francois H Geschwind; Ahmet Gurakar; Robert Anders; Andrew Cameron; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2013-06-19 Impact factor: 3.452
Authors: Maria Papaleontiou; Bradley Zebrack; David Reyes-Gastelum; Andrew J Rosko; Sarah T Hawley; Ann S Hamilton; Kevin C Ward; Megan R Haymart Journal: J Cancer Surviv Date: 2020-09-16 Impact factor: 4.062